Ticker Details
Dyne Therapeutics, Inc.
IPO Date:	September 17, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$2.45B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.51 | 3.23%
Avg Daily Range (30 D):	$0.42 | 2.44%
Avg Daily Range (90 D):	$0.58 | 3.06%

Institutional Daily Volume
Avg Daily Volume:	.85M
Avg Daily Volume (30 D):	1.6M
Avg Daily Volume (90 D):	2.18M

Trade Size
Avg Trade Size (Sh.):	85
Avg Trade Size (Sh.) (30 D):	74
Avg Trade Size (Sh.) (90 D):	80

Institutional Trades
Total Institutional Trades:	2,307
Avg Institutional Trade:	$2.52M
Avg Institutional Trade (30 D):	$2.63M
Avg Institutional Trade (90 D):	$2.31M
Avg Institutional Trade Volume:	.14M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$4.3M
Avg Closing Trade (30 D):	$4.68M
Avg Closing Trade (90 D):	$5.8M
Avg Closing Volume:	229.72K

News

Feb 22, 2026 @ 9:00 PM Dyne Therapeutics Announces Upcoming Presentations... Source: Na

Dec 10, 2025 @ 2:42 AM Dyne Therapeutics Announces Pricing of Upsized $35... Source: Dyne Therapeutics

Dec 9, 2025 @ 9:34 PM Biggest Market Movers Today, Dec. 9: WRBY, DYN, & ... Source: Dan Caplinger

Oct 27, 2025 @ 10:17 PM Why Dyne Therapeutics Stock Crushed the Market on ... Source: Eric Volkman

Sep 29, 2025 @ 12:35 PM Dyne Therapeutics Receives Orphan Drug Designation... Source: Globe Newswire

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$-3.66	$-.76	$-.97
Diluted EPS	$-3.66	$-.76	$-.97
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-423.8M	$-108.04M	$-110.86M
Operating Income / Loss	$-449.16M	$-113.89M	$-115.79M
Cost of Revenue
Net Cash Flow	$41.53M	$88.58M	$12.85M
PE Ratio